Concentrix Corporation
NASDAQ:CNXCInformation Technology Services
-$0.75 today
- Market cap
- $1.85B
- Beta
- 0.42
- P/E (TTM)
- -1.1
- EPS (TTM)
- -$21.66
- Dividend yield
- 5.73%
Volume 0.65M
Average 1.64M
CNXC Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Concentrix CorporationNASDAQ: CNXC
Operating Expenses · Q1 FY2026 · quarter ended Feb 2026
Operating expenses growth accelerates
Q1 FY2026 operating expenses of $731.1M rose 6.4% year over year, ahead of the -4.4% change in trailing-twelve-month operating expenses. Sequentially, it rose 28.8% from the prior quarter. Over 3 fiscal years it compounded at +20.4% a year.
Context
- Operating expenses amounted to 28.8% of revenue in FY2025, down 0.9 pp from a year earlier.
- Operating expenses increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +6.4% holds above the trailing-twelve-month pace of -4.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 2.83B USD
- Year-over-year change
- -0.9%
- 4-year CAGR
- +19.3%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-11-30 | 2.83B | -0.9% |
| FY2024 | 2024-11-30 | 2.85B | +48.8% |
| FY2023 | 2023-11-30 | 1.92B | +18.5% |
| FY2022 | 2022-11-30 | 1.62B | +15.7% |
| FY2021 | 2021-11-30 | 1.4B | — |
Operating Expenses vs competitors
How CNXC compares with its peers on the latest reported figures
- CNXC's LTM Feb 2026 operating expenses of $2.71B is the highest of the 9 companies compared; the peer median is $422.77M.
- Its year-over-year change of -4.4% is the 6th highest of 9, against a peer median of +4.8%.
- Operating expenses amounts to 27.2% of revenue for CNXC, versus a peer median of 24.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Feb 2026 | $2.71B | -4.4% | +20.4% | 27.2% | |
| LTM Mar 2026 | $1.51B | -23.6% | -34.9% | 61.5% | |
| LTM Sep 2026 | $1.06B | +8.2% | -1.3% | 18.8% | |
| LTM Jun 2026 | $528.3M | +17.7% | +14.7% | 23.6% | |
| LTM Apr 2026 | $524.54M | -5.7% | +1.0% | 60.2% | |
| LTM Mar 2026 | $321.01M | -47.8% | -4.0% | 15.3% | |
| LTM Mar 2026 | $144.82M | +10.8% | -0.4% | 34.9% | |
| LTM Mar 2026 | $119.93M | +1.4% | +8.6% | 19.1% | |
| LTM Jun 2026 | $81.39M | +49.3% | +16.3% | 25.7% | |
| Peer median (excluding CNXC) | $422.77M | +4.8% | +0.3% | 24.6% | |
Competitors are the stored peer set for CNXC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Nov 2021 | FY2022 Nov 2022 | FY2023 Nov 2023 | FY2024 Nov 2024 | FY2025 Nov 2025 |
|---|---|---|---|---|---|
| Revenue | 5.59B | 6.32B | 7.11B | 9.62B | 9.83B |
| Cost of Revenue | 3.62B | 4.07B | 4.54B | 6.17B | 6.39B |
| Gross Profit | 1.97B | 2.26B | 2.58B | 3.45B | 3.44B |
| Gross Margin | 35.3% | 35.7% | 36.2% | 35.9% | 35.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.4B | 1.62B | 1.92B | 2.85B | 2.83B |
| Operating Expenses | 1.4B | 1.62B | 1.92B | 2.85B | 2.83B |
| Depreciation & Amortization | 277.18M | 309.54M | 388.3M | 705.85M | 650.11M |
| EBITDA | 855.92M | 984.62M | 997.53M | 1.33B | (241.77M) |
| EBITDA Margin | 15.3% | 15.6% | 14.0% | 13.8% | -2.5% |
| Operating Income | 572.4M | 640.19M | 661.33M | 596.39M | 609.54M |
| Operating Margin | 10.2% | 10.1% | 9.3% | 6.2% | 6.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 23.05M | 70.08M | 201M | 321.83M | 290.35M |
| Other Income / Expenses | (16.7M) | (35.19M) | (253.1M) | (297.11M) | (1.79B) |
| Income Before Tax | 555.7M | 605M | 408.23M | 299.27M | (1.18B) |
| Pre-Tax Margin | 9.9% | 9.6% | 5.7% | 3.1% | -12.0% |
| Income Tax Expense | 150.12M | 169.36M | 94.39M | 48.06M | 96.7M |
| Net Income | 405.58M | 435.05M | 313.84M | 251.22M | (1.28B) |
| Net Margin | 7.3% | 6.9% | 4.4% | 2.6% | -13.0% |
| EPS (Basic) | 7.78 | 8.34 | 5.72 | 3.72 | (20.36) |
| EPS (Diluted) | 7.70 | 8.28 | 5.70 | 3.71 | (20.36) |
| Weighted Avg Shares | 51.36M | 51.35M | 53.8M | 64.98M | 63.01M |
| Weighted Avg Shares (Diluted) | 51.91M | 51.74M | 54.01M | 65.07M | 63.01M |
Concentrix Corporation
NASDAQ:CNXC
Intrinsic Alpha fair value
Locked
Current Price
$30.27
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.